ÂÜÀòÂÒÂ×

Karl Kneip is a finance professional with extensive experience in accounting and financial analysis across various companies within the pharmaceutical and healthcare sectors. Currently serving as a Sr. Accountant at Global Blood Therapeutics since December 2019, Karl Kneip has previously held roles as a Sr. Accountant at Hyperion Therapeutics and as a Contract Accountant at multiple organizations, including Portola Pharmaceuticals and Marcus & Millichap Corporate Services. Responsibilities have included managing audit preparations, conducting account reconciliations, overseeing budget variance analysis, and collaborating with financial leadership on strategic budgeting initiatives. Karl Kneip's career began in accounting at Syntex and transitioned to finance managerial roles at Roche. An MBA in Finance from Santa Clara University complements a solid educational background, including a foundational degree from Menlo College.